波士顿I型人工角膜长期结局及两性霉素B与聚维酮碘预防感染效果
PURPOSE: To evaluate the long-term outcomes, anatomic retention, and complications of Boston type I keratoprosthesis (KPro).…
要点
- 波士顿I型人工角膜解剖保留率88.9%,功能成功率44.4%。
- 眼表疾病患者并发症显著多于无眼表疾病者。
- 局部0.1%两性霉素B与5%聚维酮碘可降低感染发生率。
核心结论
- 波士顿I型人工角膜保留率与视力结局良好,可作为常规穿透性角膜移植失败患者的替代治疗。
- 在标准预防性抗生素基础上加用局部0.1%两性霉素B和5%聚维酮碘,可能是感染预防的可选有效方案。
主要发现
- 平均随访83.4±28.4个月,15眼(55.6%)最佳矫正视力改善。
- 解剖保留率88.9%,功能成功率44.4%(保留人工角膜且最佳矫正视力≥3/60)。
- 眼表疾病患者并发症显著多于无眼表疾病者。
- 最常见并发症为人工角膜后膜形成(15眼,55.6%)和感染(13眼,48.1%)。
- 感染性角膜炎主要由革兰阳性菌引起,眼内炎主要由真菌感染引起。
关键数值与推荐
- 使用局部0.1%两性霉素B的眼感染发生率显著更低(P = .008)。
- 使用5%聚维酮碘的眼感染发生率显著更低(P = .021)。
临床怎么用
- 对常规穿透性角膜移植失败患者,可考虑波士顿I型人工角膜并注重患者选择与并发症预防。
- 可考虑在标准预防性抗生素基础上加用局部0.1%两性霉素B和5%聚维酮碘预防感染,尤其在热带国家。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the long-term outcomes, anatomic retention, and complications of Boston type I keratoprosthesis (KPro). DESIGN: Retrospective, interventional case series METHODS: A retrospective chart review of implantations performed January 2008-December 2017 was conducted. Risk factors for anatomical retention and functional success were analyzed. The incidences of infections with and without antimicrobial medications were compared. RESULTS: Twenty-seven eyes of 26 patients were recruited. The most common indication for KPro surgery was failed penetrating keratoplasties (22 eyes, 81.5%). All patients had preoperative best-corrected visual acuity (BCVA) worse than 3/60. Over the mean follow-up of 83.4 ± 28.4 months, 15 eyes (55.6%) demonstrated improved BCVA. The anatomical retention rate was 88.9%, and the functional success rate was 44.4% (retained KPro with BCVA ≥ 3/60). Eyes with ocular surface disease (OSD) had significantly more complications than those without OSD. The most common complications were retroprosthetic membrane formation (15 eyes, 55.6%) and infection (13 eyes, 48.1%). Infectious keratitis was primarily caused by gram-positive bacteria, whereas endophthalmitis was chiefly caused by fungal infection. The infection incidence was significantly lower in eyes using topical 0.1% amphotericin B and 5% povidone iodine (P = .008 and .021, respectively). CONCLUSIONS: With its good retention rate and visual outcomes, Boston type I KPro could be an alternative treatment for patients with conventional penetrating keratoplasty failure, especially with appropriate patient selection and complication prevention. Standard prophylactic antibiotics with the addition of topical 0.1% amphotericin B and 5% povidone iodine might be optional effective regimens for infection prevention, especially in tropical countries.
引用
- Prabhasawat P, Chotikavanich S, Ngowyutagon P, et al. Long-term Outcomes of Boston Type I Keratoprosthesis, and Efficacy of Amphotericin B and Povidone-Iodine in Infection Prophylaxis. Am J Ophthalmol. 2021. PMID: 34102154. doi:10.1016/j.ajo.2021.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。